Heart Rhythm
Volume 7, Issue 2 , Pages 167-172 , February 2010

Outcomes and complications of catheter ablation for atrial fibrillation in females

Preliminary data were presented at the American College of Cardiology, which was held in Orlando, Florida, in March 29-31, 2009.

  • Dimpi Patel, DO

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • ,
  • Prasant Mohanty, MBBS, MPH

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • ,
  • Luigi Di Biase, MD

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • Department of Cardiology University of Foggia, Foggia, Italy
    • Department of Biomedical Engineering, University of Texas, Austin, Texas
    • ,
  • Javier E. Sanchez, MD

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • ,
  • Mazen H. Shaheen, MD

      Affiliations

    • University of Cincinnati, Cincinnati, Ohio
    • ,
  • J. David Burkhardt, MD

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • ,
  • Mohammed Bassouni, MD

      Affiliations

    • University of Cairo, Egypt
    • ,
  • Jennifer Cummings, MD

      Affiliations

    • Akron General Hospital, Akron, Ohio
    • ,
  • Yan Wang, MD

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • ,
  • William R. Lewis, MD

      Affiliations

    • Metro Health, Cleveland, Ohio
    • ,
  • Alberto Diaz, MD

      Affiliations

    • Metro Health, Cleveland, Ohio
    • ,
  • Rodney P. Horton, MD

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • Department of Biomedical Engineering, University of Texas, Austin, Texas
    • ,
  • Salwa Beheiry, RN

      Affiliations

    • California Pacific Medical Center, San Francisco, California
    • ,
  • Richard Hongo, MD

      Affiliations

    • California Pacific Medical Center, San Francisco, California
    • ,
  • G. Joseph Gallinghouse, MD

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • ,
  • Jason D. Zagrodzky, MD

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • ,
  • Shane M. Bailey, MD

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • ,
  • Amin Al-Ahmad, MD

      Affiliations

    • Stanford University, Palo Alto, California
    • ,
  • Paul Wang, MD

      Affiliations

    • Stanford University, Palo Alto, California
    • ,
  • Robert A. Schweikert, MD, FHRS

      Affiliations

    • Akron General Hospital, Akron, Ohio
    • ,
  • Andrea Natale, MD, FHRS

      Affiliations

    • St. David's Medical Center, Texas Cardiac Arrhythmia Institute, Austin, Texas
    • Department of Biomedical Engineering, University of Texas, Austin, Texas
    • Corresponding Author InformationAddress reprint requests and correspondence: Andrea Natale, M.D., Executive Medical Director of the Texas Cardiac Arrhythmia Institute, 1015 East 32d Street, Suite 506, Austin, Texas 78705

Received 24 July 2009 ,Accepted 19 October 2009.

References 

  1. Benjamin EJ, Wolf PA, D'Agostina RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–953
  2. Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol. 2005;46:1298–1306
  3. Humphries KH, Kerr CR, Connolly SJ, et al. New-onset atrial fibrillation: sex differences in presentation, treatment and outcome. Circulation. 2001;103:2365–2370
  4. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up (A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. European Heart Rhythm Association (EHRA); European Cardiac Arrhythmia Society (ECAS); American College of Cardiology (ACC); American Heart Association (AHA); Society of Thoracic Surgeons (STS)). Heart Rhythm. 2007;6:816–861
  5. Arruda M, Mlcochova H, Prasad SK, et al. Electrical isolation of the superior vena cava: an adjunctive strategy to pulmonary vein antrum isolation improving the outcome of AF ablation. J Cardiovasc Electrophysiol. 2007;18:1261–1266
  6. Kanj MH, Wazni O, Fahmy T, et al. Pulmonary vein antral isolation using an open irrigation ablation catheter for the treatment of atrial fibrillation: a randomized pilot study. J Am Coll Cardiol. 2007;49:1634–1641
  7. Bhargava M, Di Biase L, Mohanty P, et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: results from a multicenter study. Heart Rhythm. 2009;6:1403–1412
  8. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43:2044–2053
  9. Cappato R, Calkins H, Chen S, et al. Worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100–1105
  10. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;4:221–225
  11. Wong CC, Froelicher ES, Bacchetti P, et al. Influence of gender on cardiovascular mortality in acute myocardial infarction patients with high indication for coronary angiography. Circulation. 1997;96(9 Suppl):II51–II79
  12. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298:1525–1532
  13. Mahon NG, McKenna CJ, Codd MB, et al. Gender differences in the management and outcome of acute myocardial infarction in unselected patients in the thrombolytic era. Am J Cardiol. 2000;85:921–926
  14. Dagres N, Clague JR, Breithardt G, Borggrefe M. Significant gender-related differences in radiofrequency catheter ablation therapy. J Am Coll Cardiol. 2003;42:1103–1107
  15. Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007;9:613–620
  16. Corrado A, Patel D, Riedlbauchova L, et al. Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians. J Cardiovasc Electrophysiol. 2008;19:807–811
  17. Bhargava M, Marrouche NF, Martin DO, et al. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter. J Cardiovasc Electrophysiol. 2004;1:8–13
  18. Zado E, Callans DJ, Riley M, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol. 2008;19:621–626
  19. Siddharth P, Smith N, Mason R, et al. Variational anatomy of the deep femoral artery. Anatom Rec. 1985;212:206–209
  20. Hughes P, Scott C, Bodenham A. Ultrasonography of the femoral vessels in the groin: implications for vascular access. Anaesthesia. 2000;55:1198–1202

 J. David Burkhardt is a speaker for St. Jude Medical and Biosense Webster and Chief Medical Officer for Stereotaxis. Robert A. Schweikert is a consultant for Biosense Webster and a speaker for Medtronic, St. Jude Medical, Boston Scientific, Biosense Webster, and Reliant Pharmaceuticals. Andrea Natale is a speaker for St. Jude Medical, Boston Scientific, Medtronic, and Biosense Webster and a member of the Advisory Board for Stereotaxis and Biosense Webster. She also received a research grant from St. Jude Medical. Rodney Horton is on the Speakers' Bureau for Hansen Medical, St. Jude Medical, Medtronic, Boston Scientific, and Biosense Webster. Javier E. Sanchez receives speaker fees from Boston Scientific, St. Jude Medical, and Biosense Webster. G. Joseph Gallinghouse is a consultant for St. Jude Medical and Hansen Medical. All other authors have no conflicts of interest.

PII: S1547-5271(09)01189-8

doi: 10.1016/j.hrthm.2009.10.025

Heart Rhythm
Volume 7, Issue 2 , Pages 167-172 , February 2010

Article Tools

* Image Usage & Resolution